Secretory cleavage site of Alzheimer amyloid precursor protein is heterogeneous in Down's syndrome brain

FEBS Lett. 1994 Sep 5;351(2):165-7. doi: 10.1016/0014-5793(94)00851-5.

Abstract

A beta (beta/A4) is the major constituent of brain amyloid in Alzheimer's disease (AD), Down's syndrome (DS) and normal aged persons. This protein is presumably derived by normal proteolysis from a precursor protein (APP). In this study, C-terminal fragments of APP in a Tris/Triton soluble fraction were partially purified from DS brain by heparin-affinity and reverse phase chromatography, and analyzed by N-terminal amino acid sequencing after SDS polyacrylamide gel electrophoresis and Western blotting. We found at least six different C-terminal fragments including those with the entire A beta region. These results suggest that secretory processing of APP is heterogeneous and generates amyloidogenic C-terminal fragments.

Publication types

  • Comparative Study

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amino Acid Sequence
  • Amyloid beta-Protein Precursor / chemistry*
  • Amyloid beta-Protein Precursor / metabolism
  • Brain / metabolism
  • Brain Chemistry*
  • Down Syndrome* / metabolism
  • Female
  • Humans
  • Middle Aged
  • Molecular Sequence Data
  • Peptide Fragments / chemistry*
  • Peptide Fragments / metabolism
  • Sequence Analysis

Substances

  • Amyloid beta-Protein Precursor
  • Peptide Fragments